Bioworld Financial Watch articles from September 2006

Bioworld Financial Watch archives from September 2006

Valeritas' insulin patch takes aim at type II drug resisters.
September 4, 2006... "If you talk to any of the global insulin companies, and certainly if you look at Pfizer--which didn't develop insulin, but they bought inhaled capability--they will say the future of the business is devices," said Robert Gonnelli, chairman and...

10 biggest U.S. gainers for the week.(Statistical table)(Brief article)(Company rankings)
September 4, 2006... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) CytRx 46.61 SuperGen 45.37 MacroChem 33.33 Tercica 29.59 EpiCept 29.13...

10 biggest U.S. losers for the week.(Statistical table)(Company rankings)
September 4, 2006... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Corcept Thera -65.43 SGX Pharma -48.64 Cellegy Pharma -43.75 VioQuest Pharma -15.58 Acorda Therapeutics -12.31...

Collaborations between biotechnology companies and government/nonprofit institutions: May 18-Aug. 30, 2006.(Table)
September 4, 2006... Collaborations between Biotechnology Companies and Government/Nonprofit Institutions: May 18-Aug. 30, 2006 Company * University/ Type Of (Country; Symbol) Nonprofit@ Agreement Accentia Bio- ...

Bioworld stock report for public biotechnology companies.(Statistical table)
September 4, 2006... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close 8/25 9/1 Aastrom Biosci ASTM 1.18 1.2 Acadia Pharma ...

It's a pain: Adolor Phase III results mixed--what next?(Others Fight Over Generic, Term)
September 11, 2006... Adolor Corp.'s equivocal outcome last week of Phase III trials with Entereg (alvimopan) for opioid-induced bowl dysfunction might have handicapped the drug in its race with methylnaltrexone, developed by Progenics Pharmaceuticals Inc., and...

10 biggest U.S. gainers for the week.(bitechnology companies)(Statistical table)(Brief article)
September 11, 2006... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Cellegy Pharma 66.67 Avax Technologies 53.85 EXACT Sciences 37.97 Cyclacel Pharma 23.66 Deltagen 21.15 Matritech 19.30 Cholestech...

10 biggest U.S. losers for the week.(biotechnology companies)(Statistical table)(Brief article)
September 11, 2006... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Genta -66.45 Adolor -47.17 EpiCept -34.34 Martek Biosciences -30.00 Ortec Intl. -23.53 Transgenomic -23.19...

Public financings of biotechnology: August 2006.(Statistical table)
September 11, 2006... Public Financing Of Biotechnology: August 2006 I. COMMENCED TRADING IN AUGUST Shares Company Date Date Shares/ Out (Symbol) # Filed ...

Other financings of public biotechnology companies: August 2006.(Statistical table)
September 11, 2006... Other Financings Of Public Biotechnology Companies: August 2006 TOTAL: $124.09 Number Of Shares, Units Amount Company Type Of Or...

Venture Capital and other investment in private biotechnology companies: August 2006.(Statistical table)
September 11, 2006... Venture Capital And Other Investments In Private Biotechnology Companies: August 2006 FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $577.95M Company Location Date Amt. (M) Ablynx NV Ghent,...

Milestone payments from corporate partners: August 2006.(Statistical table)
September 11, 2006... Milestone Payments From Corporate Partners: August 2006 TOTAL: $12.8M Year to Date: $472.87M Company Partner Amt. Triggering (Symbol) # * (Country) (M) Event Ambrilia ...

Money raised by biotech in 2006: January-August.(Statistical table)
September 11, 2006... Money Raised By Biotech In 2006: January-August Type of financing January February March April May Public offerings 542.2 486.8 922.3 574.3 267.8 Private biotechs 476.3 306.3 ...

BioWorld stock report for public biotechnology companies.(Statistical table)
September 11, 2006... BioWorld Stock Report For Public Biotechnology Companies Close Close Company Symbol 9/1 9/8 Aastrom Biosci ASTM 1.2 1.15 Acadia Pharma ACAD 8.66...

Avastin breast cancer blip: time to buy, analyst says.(Docs Still Like Genentech's Drug)
September 18, 2006... Already getting the colloquial hairy eyeball from some observers because of slowed (though still strong) sales, Avastin stumbled further last week on news that the FDA wants more information about breast cancer trials, pushing approval back...

10 biggest U.S. gainers for the week.(biotechnology companies)(Statistical table)(Brief article)
September 18, 2006... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Stratagene 53.35 Discovery Labs 29.01 Genta 23.53 Threshold Pharma 21.88 Cell Therapeutics 19.63...

10 biggest U.S. losers for the week.(biotechnology companies)(Statistical table)(Brief article)
September 18, 2006... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Sunesis Pharma -18.00 Critical Therapeutics -16.57 Acorda Therapeutics -14.64 Cellegy Pharma -13.33 Titan Pharma -13.33 Poniard...

Clinical trials update: August 2006.(Table)
September 18, 2006... Clinical Trials Update: August 2006 Company * Product Description (Country; Symbol) AUTOIMMUNE Genentech Inc. Rituxan Rituximab; antibody that (NYSE:DNA) and (FDA-approved) ...

Non-U.S. clinical trials and regulatory actions: August 2006.(Table)
September 18, 2006... Non-U.S. Clinical Trials And Regulatory Actions: August 2006 Company* Product Description (Country; Symbol) AUTOIMMUNE Novogen NV-52 Synthetic analogue based Ltd. (Australia; ...

FDA submissions, approvals and other actions: August 2006.
September 18, 2006... FDA Submissions, Approvals And Other Actions: August 2006 Company * Product Description (Country; Symbol) AUTOIMMUNE Centocor Inc. Remicade Infliximab; monoclonal (unit of Johnson ...

BioWorld stock report for public biotechnology companies.(Table)
September 18, 2006... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close 9/8 9/15 Aastrom Biosci ASTM 1.15 1.32...

ImClone at odds with Yeda as fighting rages in ranks.
September 25, 2006... The worst could be yet to come, but ImClone Systems Inc. last week felt the initial sting of a court decision favoring an Israeli firm, Yeda Research and Development Co., that claimed sole ownership of a patent covering the use of monoclonal...

10 biggest U.S. gainers for the week.(biological products industry)(Statistical table)(Brief article)
September 25, 2006... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Kosan Biosciences 27.01 Genelabs Techno 26.02 Genta 23.81 Serono S.A. 23.40 CytRx 20.83 Alteon 20.00...

10 biggest U.S. losers for the week.(Biological products industry)(Statistical table)(Brief article)
September 25, 2006... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Ortec Intl. -38.40 EPIX Pharma -21.02 EXACT Sciences -19.45 Corcept Thera -16.80 Diversa -14.73 Neose Technologies ...

Collaborations between biotech and pharmaceutical companies: July 20-Sept. 20, 2006 #.(Table)
September 25, 2006... Collaborations Between Biotech And Pharmaceutical Companies: July 20-Sept. 20, 2006 # Biotech Co. * Pharma Co. Type/Product Area (Country; (Country) Symbol) AEterna Nippon Kayaku ...

Manufacturing, marketing and distribution agreements between biotech and pharmaceutical companies: July 20-Sept. 20, 2006 #.(Table)
September 25, 2006... Manufacturing, Marketing And Distribution Agreements Between Biotech And Pharmaceutical Companies: July 20-Sept. 20, 2006 # Biotech Co. * Pharma Co. Product (Country; (Country) Symbol) Clinical Data ...

BioWorld stock report for public biotechnology companies.(biotechnology industries)(Statistical table)
September 25, 2006... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close 9/15 9/22 Aastrom Biosci ASTM 1.32 1.19 Acadia Pharma ACAD ...